April 21, 2012 - ReproTech, Ltd. sponsors Race for the Cure teams.
ReproTech was proud to sponsor its employees and their teams for two Race for the Cure events. ReproTech's Fertility Preservation manager, Joy, and family and friends participated in Savannah's Race for the Cure, which brough nearly 5,000 participants out to raise funds for breast cancer research.
ReproTech also sponsored its Florida site director, Heather, and family and friends, in South Florida's Race for the Cure in January, held in West Palm Beach. An estimated 20,000 participated in this race, with donations surpassing $2 million. The city of West Palm Beach went all out, with the Royal Park Bridge and city lights all in pink to commemorate the 30th anniversary of the Race for the Cure.
ReproTech regularly sponsors or contributes funds to cancer fundraising events in the areas where its employees and three regional facilities reside, Ft. Lauderdale/Coconut Creek, FL; Minneapolis/St. Paul, MN and Reno, NV. Previous events sponsored by ReproTech include various Race for the Cure and Pancreatic Cancer Action Network (PANCAN) events, Lance Armstrong Foundation events and other local events benefitting cancer survivors and research. Upcoming Twin Cities events include its Race for the Cure on Mother's Day, May 13, and the Hartford RE/MAX Results Breast Cancer Ride on August 4-5.
For the 140,000 American men and women under age 45 who are newly diagnosed with cancer each year, chemotherapy and other treatments can affect their reporoductive system and fertility. Once diagnosed, there is often a small window of time for these men and women to preserve their fertility; therefore, access to cryopreservation services is extremely important. ReproTech organized its Fertility Preservation Network to eductate oncoloy professionals and caretakers, as well as provide the much needed cryopreservation services for men and women. The Network now includes members in 33 states and the Caribbean. Additionally, the work of organizations such as fertileHope and LiveSTRONG has advanced the awareness of the need for Fertility Preservation among the oncology community.